The Oncology Institute discusses financial results in earnings call

The Oncology Institute held its fourth-quarter earnings call for 2024 on March 25, 2025. The call was led by Mark Hueppelsheuser, the company's General Counsel. He welcomed participants and mentioned that the results are available on their website. The call included guidelines regarding forward-looking statements and financial measures. These statements involve risks that could lead to different actual outcomes. Investors can find more details in the company's SEC filings. Joining Hueppelsheuser were CEO Daniel Virnich and CFO Rob Carter. After their prepared remarks, they invited questions from the audience. The call is expected to last for an hour. A replay of the call will be available on the company's website following its conclusion.